SEC Filings
Filing date | Description | Form | Filing Group | Issuer | View |
---|---|---|---|---|---|
View HTML | An amendment to a SC 13D filing |
SC 13D/A |
3,4,5
|
Eidos Therapeutics, Inc. | |
View HTML | Initial filing by director officer or owner of more than ten percent. |
3 |
3,4,5
|
Eidos Therapeutics, Inc. | |
View HTML | Statement of changes in beneficial ownership of securities |
4 |
3,4,5
|
Eidos Therapeutics, Inc. | |
View HTML | Report of unscheduled material events or corporate event |
8-K |
Current Reports
|
Eidos Therapeutics, Inc. | |
View HTML | Statement of changes in beneficial ownership of securities |
4 |
3,4,5
|
Eidos Therapeutics, Inc. | |
View HTML | Report of unscheduled material events or corporate event |
8-K |
Current Reports
|
Eidos Therapeutics, Inc. | |
View HTML | Initial filing by director officer or owner of more than ten percent. |
3 |
3,4,5
|
Eidos Therapeutics, Inc. | |
View HTML | Statement of changes in beneficial ownership of securities |
4 |
3,4,5
|
Eidos Therapeutics, Inc. | |
View HTML | Statement of changes in beneficial ownership of securities |
4 |
3,4,5
|
Eidos Therapeutics, Inc. | |
View HTML | Statement of changes in beneficial ownership of securities |
4 |
3,4,5
|
Eidos Therapeutics, Inc. |
Displaying 11 - 20 of 55 results
Copyright Morningstar